Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CALM1 | P0DP23 | 1/20 | 0.57 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.46 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.46 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.46 |
| ▸ | CYP2E1 | P05181 | 1/20 | 0.44 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.44 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.44 |
| ▸ | LTA4H | P09960 | 4/20 | 0.42 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.41 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.41 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.41 |
| ▸ | IDO1 | P14902 | 1/20 | 0.41 |
| ▸ | TDO2 | P48775 | 1/20 | 0.41 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.41 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.41 |
| ▸ | IDH1 | O75874 | 1/20 | 0.39 |
| ▸ | DRD2 | P14416 | 1/20 | 0.38 |
| ▸ | DRD3 | P35462 | 1/20 | 0.38 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.38 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL27477992 | 0.88 | LMNA (0.52) | CALM1SLC6A2SLC6A3LTA4HPTGS1 | |
| SCHEMBL25364878 | 0.87 | CYP2E1 (0.54) | CALM1TAAR1SLC6A2SLC6A3CYP2E1 | |
| SCHEMBL9357255 | 0.87 | TAAR1 (0.56) | TAAR1SLC6A2SLC6A3LTA4HCYP17A1 | |
| SCHEMBL4059254 | 0.81 | TAAR1 (0.58) | TAAR1SLC6A2SLC6A3CYP2E1CYP2A6 | |
| Benzylamine SCHEMBL6665627 | 0.77 | LOXL2 (0.61) | TAAR1SLC6A2SLC6A3CYP2E1CYP2A6 | |
| SCHEMBL9732005 | 0.77 | TAAR1 (0.54) | TAAR1SLC6A2SLC6A3IDO1DRD2 | |
| SCHEMBL1712137 | 0.77 | TAAR1 (0.43) | TAAR1SLC6A2SLC6A3LTA4HCYP17A1 | |
| SCHEMBL5652167 | 0.77 | ESR1 (0.61) | TAAR1LTA4HCYP17A1CYP11B1CYP11B2 | |
| SCHEMBL20751464 | 0.77 | IDH1 (0.46) | TAAR1CYP2A6LTA4HCYP17A1CYP11B1 | |
| SCHEMBL28180421 | 0.77 | LTA4H (0.44) | TAAR1LTA4HCYP17A1CYP11B1CYP11B2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 110 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109384779-A | One kind can the hypochlorous fluorescent nano probe of ratio test and its preparation method and application | 湖南科技大学 | 2019-02-26 | — | — | CN | claimed |
| CN-109311942-A | Angiotensin-1 receptor antagonists | 辉凌公司 | 2019-02-05 | — | — | CN | claimed |
| CN-109183081-A | A kind of preparation method of additive for electrolytic copper foil and dual light electrolytic copper foil | 邵武永太高新材料有限公司 | 2019-01-11 | — | — | CN | claimed |
| CN-107236976-B | Leveling agent, the metal plating compositions containing it and preparation method, application | 上海新阳半导体材料股份有限公司 | 2018-11-16 | — | — | CN | claimed |
| CN-106660954-A | Substituted azaspiro(4.5)decane derivatives | 格吕伦塔尔有限公司 | 2017-05-10 | — | — | CN | claimed |
| US-20090014920-A1 | POLYMER FILAMENTS | MASSEY UNIVERSITY (NZ) | 2009-01-15 | — | — | US | claimed |
| WO-2006001719-A1 | POLYMER FILAMENTS | MASSEY UNIVERSITY (NZ) | 2006-01-05 | — | — | WO | claimed |
| CN-118852135-A | N-acyl sulfonamide compound, preparation method, pharmaceutical composition and application thereof | 中国医学科学院药物研究所 | 2024-10-29 | — | — | CN | disclosed |
| US-12016312-B2 | Animal models, screening methods, and treatment methods for intraocular diseases or disorders | Smilebiotek Zhuhai Limited (CN) | 2024-06-25 | — | — | US | disclosed |
| WO-2024073410-A1 | TERNARY SOLVENT ELECTROLYTES FOR HIGH VOLTAGE AND HIGH RATE LITHIUM BATTERIES | SEPION TECHNOLOGIES, INC. (US) | 2024-04-04 | — | — | WO | disclosed |
| CN-110527069-A | A kind of electroluminescent polymer and the preparation method and application thereof | UNIV SOUTH CHINA TECH | 2019-12-03 | — | — | CN | disclosed |
| CN-106715396-B | Optical activity alpha-trifluoromethyl-beta-aminoacid-derivatives preparation method | 公益财团法人微生物化学研究会 | 2019-09-27 | — | — | CN | disclosed |
| CN-110177783-A | Hormone receptor modulators for the treatment of metabolic conditions and disorders | 阿德利克斯股份有限公司 | 2019-08-27 | — | — | CN | disclosed |
| EP-0180082-A1 | Use of electrically conductive polymers for the absorption of infrared radiation | BASF Aktiengesellschaft (DE) | 1986-05-07 | — | — | EP | disclosed |
| EP-0167798-A2 | Process for manufacturing p-doped polyheterocycles | BASF Aktiengesellschaft (DE) | 1986-01-15 | — | — | EP | disclosed |
| EP-0165753-A2 | Herbicidal thiophenesulfonamides and pyridinesulfonamides | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1985-12-27 | — | — | EP | disclosed |
| US-4560534-A | Polymer catalyst transducers | MILES LABORATORIES, INC. (US) | 1985-12-24 | — | — | US | disclosed |
| EP-0140322-A2 | Polymer catalyst transducers and use thereof in test kits for analytical methods | MILES INC. (US) | 1985-05-08 | — | — | EP | disclosed |
| US-4390706-A | Process for the recovery of pure nitriles | DEGUSSA AKTIENGESELLSCHAFT (DE) | 1983-06-28 | — | — | US | disclosed |
| US-4369322-A | WITH CYANOGEN CHLORIDE | DEGUSSA AG (DE) | 1983-01-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12016312-B2 | Animal models, screening methods, and treatment methods for intraocular diseases or disorders | MB, MYOC, PDE6A | CALM1 3826/4885TAAR1 1137/4885SLC6A2 2914/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.